Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11202475rdf:typepubmed:Citationlld:pubmed
pubmed-article:11202475lifeskim:mentionsumls-concept:C0751674lld:lifeskim
pubmed-article:11202475pubmed:issue1lld:pubmed
pubmed-article:11202475pubmed:dateCreated2001-1-30lld:pubmed
pubmed-article:11202475pubmed:abstractTextLymphangioleiomyomatosis (LAM), a rare disorder of unknown cause that occurs almost exclusively in women of childbearing years, is characterized microscopically by abnormal smooth muscle proliferation in the lung, lymphatics, and mediastinal, abdominal and lower cervical lymph nodes. LAM is associated with progressive dyspnea, recurrent pneumothoraces, chylous effusions, abdominal tumors (angiomyolipoma), and chylous ascites. Because of the predilection of this disease for young women, therapies to date have mainly involved hormonal manipulation. Although the efficacy of these therapies has not been established, the clinical course is more favorable in recent studies compared with earlier reports.lld:pubmed
pubmed-article:11202475pubmed:languageenglld:pubmed
pubmed-article:11202475pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11202475pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11202475pubmed:statusMEDLINElld:pubmed
pubmed-article:11202475pubmed:monthJanlld:pubmed
pubmed-article:11202475pubmed:issn0002-9629lld:pubmed
pubmed-article:11202475pubmed:authorpubmed-author:KellyJJlld:pubmed
pubmed-article:11202475pubmed:authorpubmed-author:MossJJlld:pubmed
pubmed-article:11202475pubmed:issnTypePrintlld:pubmed
pubmed-article:11202475pubmed:volume321lld:pubmed
pubmed-article:11202475pubmed:ownerNLMlld:pubmed
pubmed-article:11202475pubmed:authorsCompleteYlld:pubmed
pubmed-article:11202475pubmed:pagination17-25lld:pubmed
pubmed-article:11202475pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:meshHeadingpubmed-meshheading:11202475...lld:pubmed
pubmed-article:11202475pubmed:year2001lld:pubmed
pubmed-article:11202475pubmed:articleTitleLymphangioleiomyomatosis.lld:pubmed
pubmed-article:11202475pubmed:affiliationPulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.lld:pubmed
pubmed-article:11202475pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11202475pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11202475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11202475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11202475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11202475lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11202475lld:pubmed